Wednesday, September 3, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Colorectal Cancer Exhibits Distinct Microbial Signature, DNA Analysis Reveals

September 3, 2025
in Cancer
Reading Time: 4 mins read
0
65
SHARES
592
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking new study spearheaded by researchers at the University of East Anglia (UEA), an unprecedented microbial signature has been identified uniquely associated with colorectal cancer, reshaping long-standing paradigms in oncology and microbial genomics. This extensive research, analyzing whole genome sequencing (WGS) data from over 9,000 cancer patients, delves into the intricate relationships between human tumours and their microbial inhabitants, revealing novel insights that could revolutionize cancer diagnostics and treatment. Published in Science Translational Medicine, the findings not only challenge the conventional notion that all cancers possess distinct microbial fingerprints but also spotlight the profound clinical potential of microbial detection in precision medicine.

Colorectal cancer, the fourth most common and the second deadliest cancer in the United Kingdom, has long presented challenges in early diagnosis and effective treatment stratification. The UEA team’s discovery that colorectal tumours harbor specific and identifiable microbial communities opens a new frontier in oncological research and clinical practice. Unlike other tumour types, which did not exhibit unique microbial signatures according to this exhaustive analysis, colorectal cancers stood out with their distinctive microbial DNA profiles, suggesting a direct or indirect association between tumour development and the microbiota ecosystem within the tumour microenvironment.

This revelation stems from an innovative approach wherein researchers utilized whole genome sequencing data sourced from 11,735 cancer samples spanning 22 different cancer types, gleaned from Genomics England. The sequencing not only captured human genomic material but also inadvertently obtained microbial DNA harbored within the tumour tissue. By developing sophisticated computational algorithms, the team meticulously filtered out human DNA to isolate microbial genomic sequences, enabling precise characterization of the tumor-associated microbiome across diverse cancer types. This dual-genomic analysis permitted the correlation of microbial presence and composition with tumour characteristics and clinical outcomes, marking a crucial advance over prior studies constrained to limited microbial assays or smaller sample sizes.

Contrary to previously held assumptions in the oncology community that each cancer type might possess a unique microbial fingerprint, the UEA study reveals a more complex reality. While colorectal tumours exhibited clear and distinctive microbial communities, other cancers showed no such consistent or specific microbial signatures. This nuanced finding compels a reassessment of the role microbes play across different cancer types, emphasizing that microbial influence may not be uniformly distributed or functionally significant in all tumours, but rather may be cancer-type specific.

Importantly, the study also illuminated compelling viral dynamics in oral cancers. Detection of oncogenic viruses such as human papillomavirus (HPV) and more obscure but clinically perilous pathogens like Human T-Lymphotropic Virus-1 (HTLV-1) within oral tumour samples underscores the utility of WGS in revealing silent viral infections that may exacerbate or contribute to oncogenesis. The capacity to detect such viruses with higher precision compared to conventional medical diagnostics not only aids in more accurate cancer typing but also suggests therapeutic avenues targeting viral components within tumours.

Further broadening the clinical implications, the observed association between certain bacterial species and survival rates in sarcoma patients signals a potential prognostic role for the tumour microbiome. Some bacteria correlated with poorer outcomes, corroborating hypotheses that microbial dysbiosis might influence tumour aggressiveness or patient resilience. Intriguingly, the presence of other bacterial taxa was linked with improved survival, indicating that microbes may modulate host immune responses or tumour biology in complex and potentially beneficial ways. These insights pave the way for research aimed at harnessing microbes as biomarkers or even adjuvant therapeutic agents in sarcoma and possibly other refractory cancers.

As whole genome sequencing becomes increasingly ingrained within routine hospital diagnostics, the integration of microbial analysis presents a low-cost, high-yield augmentation of cancer profiling. Computational techniques to extract microbial data from existing WGS outputs do not require additional sample collection or laboratory procedures, making microbial detection a cost-effective adjunct to genomic diagnostics. The UEA team emphasizes that this approach could transform cancer care by offering more precise diagnostic tools, prognostic indicators, and personalized treatment strategies grounded in the tumour microenvironment’s microbial landscape.

This multidisciplinary research, undertaken in collaboration with leading institutions including the University of Leeds, Quadram Institute, Oxford Nanopore Technologies, Institute of Cancer Research London, and others, represents a leap forward in precision medicine. The achievements underscore the synergy between advanced sequencing technologies, bioinformatics, and clinical oncology, illustrating how integrating microbial genomics with patient data can unearth hidden facets of cancer biology with direct translational potential.

The study also accentuates the indispensable role of genomic medicine in identifying occult infections that may evade traditional detection yet bear significant implications for patient outcomes. Prof Daniel Brewer of UEA highlights the clinical relevance of detecting viruses like HTLV-1 and HPV, pathogens capable of influencing cancer prognosis and treatment resistance. By incorporating comprehensive genomic profiling into routine clinical pipelines, these hidden viral infections become detectable, thereby enabling timely interventions and informed decision-making.

Moreover, the findings shed light on novel diagnostic considerations in oral cancer, given the proximity and frequent detection of viral agents that often act as oncogenic cofactors. This suggests that oral cancer diagnosis and treatment planning could benefit substantially from genomic insights into microbial composition. The study invites a reimagining of cancer diagnostics where the tumour microenvironment’s microbial inhabitants are considered integral components influencing disease progression and therapeutic response.

This research was generously supported by a consortium of funding bodies including the Big C Cancer Charity, Prostate Cancer UK, The Bob Champion Cancer Trust, Movember, and Sarcoma UK, among others. The collaborative effort exemplifies the critical role of interdisciplinary funding and institutional cooperation in driving groundbreaking discoveries at the nexus of genomics, microbiology, and oncology.

Published on September 3, 2025, in Science Translational Medicine, this study entitled “Microbial Clues in Cancer: New Study Challenges Old Assumptions and Reveals Clinical Potential” not only advances scientific understanding but also has the potential to catalyze a paradigm shift in cancer management worldwide. As cancer treatment steadily transitions towards precision and personalized medicine, incorporating microbiome profiling alongside genomic sequencing promises to unlock new layers of biological complexity, offering hope for improved diagnostics, prognostics, and therapeutic innovation.

In conclusion, the identification of colorectal cancer’s unique microbial fingerprint defies prior assumptions while highlighting the untapped potential of leveraging tumour-associated microbes in clinical oncology. This work exemplifies how sophisticated genome-wide analyses combined with microbial detection can yield transformative insights, ultimately enhancing patient outcomes and steering cancer care toward a future where the microbiome is a vital ally in the fight against cancer.


Subject of Research: People

Article Title: Microbial Clues in Cancer: New Study Challenges Old Assumptions and Reveals Clinical Potential

News Publication Date: 3-Sep-2025

References: ‘Microbial Clues in Cancer: New Study Challenges Old Assumptions and Reveals Clinical Potential,’ Science Translational Medicine

Keywords: colorectal cancer, microbial fingerprint, tumour microbiome, whole genome sequencing, HPV, HTLV-1, sarcoma, cancer diagnosis, microbial oncology, precision medicine, tumour microenvironment, viral oncogenesis

Tags: cancer diagnostics and treatmentcancer patient microbiome analysiscolorectal cancer microbial signaturedistinct microbial communities in cancerearly diagnosis colorectal cancermicrobial detection in precision medicinemicrobial genomics in oncologyoncology research breakthroughsprecision medicine and microbiotatumour microenvironment and microbiomeUEA colorectal cancer studywhole genome sequencing cancer research
Share26Tweet16
Previous Post

Preoperative Oral Health Care Linked to Reduced Postoperative Pneumonia and Shorter Hospital Stays, Japanese Study Finds

Next Post

Therapeutic Effects of Allium tuncelianum on Blastocystis

Related Posts

blank
Cancer

High-Throughput Antibody Testing Platform Poised to Accelerate Disease Research and Therapeutic Advances

September 3, 2025
blank
Cancer

4D-Printed Microdevices Detect Pancreatic Cancer Biomarkers

September 3, 2025
blank
Cancer

New Study Uncovers Connection Between Excessive Alcohol Consumption and Fatty Liver Disease

September 3, 2025
blank
Cancer

Sugar-coated nanoparticles show promise in targeting deadly breast cancer

September 3, 2025
blank
Cancer

SERAPHINA Study: Nab-Paclitaxel Benefits in HER2-Negative Cancer

September 3, 2025
blank
Cancer

Genetic Variants and Ancestry Impact Colorectal Cancer Risk

September 3, 2025
Next Post
blank

Therapeutic Effects of Allium tuncelianum on Blastocystis

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27544 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    958 shares
    Share 383 Tweet 240
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    510 shares
    Share 204 Tweet 128
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • New Meta-Analysis Reveals GeneSight Testing Significantly Boosts Depression Treatment Outcomes
  • Scientists Discover Single Antibody Triggering Severe Reaction to Widely Used Blood Thinner
  • Revolutionary Design Framework Simplifies Development of Custom Shock-Absorbing Materials
  • Ochsner Health Recognized by AMA for Excellence in Joy in Medicine Initiative

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading